Press Releases

COVID19 State Emergency Plans Confirm Medical Cannabis is Essential

Posted by · March 25, 2020 12:15 PM

Patient Advocates are Grateful States are Listening, Warn “There is More Action Still Needed”

WASHINGTON, DC — Last Monday, March 16, Americans for Safe Access (ASA), the nation's largest medical cannabis patient advocacy organization, with coordinated stakeholders and allies, called on U.S. state and territorial governors (DC mayor) and medical cannabis program directors to allow cannabis businesses and dispensaries to remain open as “essential” businesses during COVID-19-related closings as well as a list of other measures that they should immediately put into place to protect patient access and the medical cannabis supply chain.

Read more

Medical Cannabis Patients, Medical Professionals, Advocates, and Industry Leaders Will Converge Online for the 2020 National Medical Cannabis Unity Conference

Posted by · March 23, 2020 2:07 PM

WASHINGTON, DC — On Friday, March 27, 2020, Americans for Safe Access (ASA) will hold its 8th Annual National Medical Cannabis Unity conference. This year, for the first time ever, the conference will be held online due to the COVID-19 outbreak. Instead of cancelling or postponing the conference, ASA decided to move this year’s Unity Conference from an in-person conference to an online conference in order to make their program content available to participants across the country. From 12 p.m. to 6 p.m. ET, ASA will share the latest developments in medical cannabis, discuss barriers to medical cannabis access, exchange ideas about how to navigate medical cannabis policy--nationally and globally--in this ever-changing political landscape, and demand action from state and federal elected officials.

Read more

COVID-19 Press Release

Posted by · March 16, 2020 6:48 PM

Medical Cannabis Patient Advocates Call on Governors to Protect Patients Amid Covid-19 Outbreak

Americans for Safe Access Provides Governors, Mayors, Medical Cannabis Program Directors with Action List 

Washington, DC -- Americans for Safe Access (ASA) sent out a letter today to call on governors and directors of state medical cannabis programs to take immediate action to ensure that patients continue to have access to medical cannabis and that the supply chain is not interrupted while Governors are creating emergency plans in their states to address the COVID-19 pandemic.

Read more

Keystone State Testing Lab Receives National Certification from Patient Focused Certification Program

Posted by · March 16, 2020 12:58 PM

Washington, DC -- We are pleased to announce that Keystone State Testing Laboratory of Harrisburg, PA has been certified for laboratory analysis of cannabis products under our dual Patient Focused Certification (PFC)/ISO 17025 laboratory accreditation program in partnership with the American Association of Laboratory Accreditation (A2LA). PFC is the only nonprofit third-party certification program for the cannabis industry based on quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopoeia (AHP). ISO 17025 is an internationally recognized laboratory standard for Testing and Calibration Laboratories, and is a required standard for many cannabis testing labs. Working with A2LA we have combined them into the most complete laboratory certification available.

Read more

Colorado Cannabis Laboratory Achieves National Certification

Posted by · January 09, 2020 12:46 PM

Americans for Safe Access (ASA) is pleased to announce that PhytaTech Laboratory of Denver, CO has been certified for laboratory analysis of cannabis products under ASA’s dual Patient Focused Certification (PFC)/ISO 17025 laboratory accreditation program that is done through the American Association of Laboratory Accreditation (A2LA). PFC is a project of ASA, and the only nonprofit third-party certification program for the cannabis industry based on quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopoeia (AHP). ISO 17025 is an internationally recognized laboratory standard for Testing and Calibration Laboratories, and is a required standard for many cannabis testing labs.

Read more

ASA Applauds Passage of MORE Act in House Committee

Posted by · November 20, 2019 12:30 PM

Washington, DC -- Americans for Safe Access (ASA) applauds the passage of H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), in the House Judiciary Committee today. The act, which includes elements from several cannabis-reform bills recently put forward in Congress, would, among other things, federally deschedule and decriminalize cannabis, provide for reinvestment in certain people adversely impacted by the War on Drugs, and provide for the expungement of certain cannabis offenses.

The Drug Enforcement Administration (DEA) currently classifies cannabis under Schedule I of the Controlled Substances Act, a designation given to substances thought to have a high potential for abuse and no medical value. (For perspective, other Schedule I substances include LSD and heroin.) It is federally illegal for cannabis and other Schedule I substances to be “prescribed, dispensed, or administered for medical use.”

Read more

ASA Creates Patient-Focused Recommendations in Light of the Vaping Crisis

Posted by · October 02, 2019 11:18 AM

Washington, DC -- In light of the emergence of Vaping-Associated Pulmonary Illness (VAPI), which has sickened at least 805 people and killed 12, Americans for Safe Access (ASA) strongly recommends that patients and consumers stop using cannabis-containing cartridges entirely (or at least to the extent possible) until there is clarity as to what is causing these illnesses and deaths. Patients and consumers are encouraged to use other legal delivery mechanisms that may be available to them in their state, such as dry herb (flower) vaporizers, tinctures, edibles, or topicals. 

ASA does not support outright bans on cannabis-containing cartridges or devices intended for the consumption of cannabis concentrates, which could cause more people to the unregulated market and exacerbate the spread of VAPI. Rather, we recommend bans on the inclusion of any additives (e.g., diluents, thickeners, flavoring agents) not derived from cannabis. Additionally, we urge that patients and consumers only purchase cannabis products that have undergone testing at an independent, third-party laboratory that has verified composition and potency and screened for adulterants, contaminants, heavy metals, residual solvents, chemical residues, and other health concerns, such as mold and dangerous bacteria.

Read more

Americans for Safe Access Urges California Governor Gavin Newsom to Sign SB 34

Posted by · September 24, 2019 2:18 PM

Washington, DC — Americans for Safe Access urges California Governor Gavin Newsom to sign SB 34Cannabis: Donations, which passed in the California state legislature on September 11, 2019. SB 34 would exempt medical cannabis from California state taxes.  Governor Newsom has until October 13, 2019 to sign or veto the bill. 

When California became the first state in the nation to develop a medical cannabis program in 1996, it was centered around compassion and access to medicine, not commercialization. Since the passage of the Control, Regulate and Tax Adult Use of Marijuana Act (AUMA), nonprofit medical operators have suffered the unintended consequence of being faced with a tremendous tax burden based on the amount of cannabis they distribute, even if it was given away for free. Due to AUMA, nonprofit providers face taxes of up to $1,000 per pound for the cannabis they distribute free of charge, even if they do not have an operating budget and are volunteer-run organizations. Many medical cannabis storefronts closed as a result, causing a dearth of affordable cannabis products for patients. 

Read more

ASA Urges FDA to Implement Good Manufacturing Principles for Vaporization Products

Posted by · September 18, 2019 9:40 AM

Washington, DC — In a letter to the heads of the U.S. Food & Drug Administration (FDA), the Centers for Disease Control and Prevention, and the U.S. Department of Health and Human Services, Americans for Safe Access calls for the safe regulation of vaporization products and cartridges. As part of its recommendations, ASA urges the FDA to use its regulatory authority to, at minimum, issue guidance that encourages consumers to only buy vaporization products in legal, licensed stores and not on the illicit market.

“The ongoing health crisis attributed to vaping highlights the need for regulations on issues such as third-party testing and accurate labeling,” said Heather Despres, Director of Americans for Safe Access’ Patient Focused Certification program. “For many medical cannabis patients, vaporization is a popular delivery method. Patients have a right to know what is in their medicine, and the FDA should recognize that the only way to prevent further health complications from vaping products is to allow a lawful, regulated marketplace for them to exist.”

Read more

Americans for Safe Access Unveils Medical Cannabis Patient’s Guide for U.S. Travel 

Posted by · August 29, 2019 10:29 AM

Washington, DC -- Americans for Safe Access (ASA) has released The Medical Cannabis Patient’s Guide for U.S. Travel in conjunction with the start of Labor Day weekend. This guide will help traveling patients understand the laws regarding access to cannabis in the states and territories that extend reciprocity to patients from other jurisdictions or permit the adult use of cannabis and will provide patients with a clear sense of how to obtain cannabis while traveling outside of their home jurisdictions. The guide also contains helpful tips for patients to bear in mind while traveling.

Read more